Advances in predictive biomarkers associated with immunotherapy in extensive-stage small cell lung cancer

Abstract Small cell lung cancer (SCLC) is a highly malignant and poor-prognosis cancer, with most cases diagnosed at the extensive stage (ES). Amidst a landscape marked by limited progress in treatment modalities for ES-SCLC over the past few decades, the integration of immune checkpoint inhibitors...

Ausführliche Beschreibung

Bibliografische Detailangaben

Hauptverfasser:	Tong Chen, Mingzhao Wang, Yanchao Chen, Yang Cao, Yutao Liu
Format:	Artigo
Sprache:	Inglês
Veröffentlicht:	BMC 2024-09-01
Schriftenreihe:	Cell & Bioscience
Schlagworte:	Small cell lung cancer Extensive stage Immune checkpoint inhibitors Immunotherapy Efficacy Predictive biomarkers
Online-Zugang:	https://doi.org/10.1186/s13578-024-01283-9
Tags:	Tag hinzufügen Keine Tags, Fügen Sie das erste Tag hinzu!